The future of targeted therapies
Advancing cures and transforming lives for patients in need
Device-based Delivery: Extroducer®
The Extroducer is a novel, modality-agnostic endovascular infusion catheter with the ability to delivery payload directly to targeted cardiac and pancreatic tissues and solid tumors.
Cell Therapies
We are developing novel stem cell-based therapies for tissue repair in cardiac failure and Parkinsons’ disease using unique progenitor cell technology.
Modified Cell Therapies
We are currently investigating cell-mediated mRNA therapy technologies as we build out our targeted therapies portfolio.
We are
ScientistsInnovatorsEntrepreneursVisionaries
We combine first-in-class delivery and therapy tech
We are advancing healthcare through innovative cell-based therapies and cutting-edge drug delivery technologies to address critical health needs.
Founded in 2014
Tullinge, Sweden
80+ Employees
20 Nationalities
Explore recent breakthroughs and industry trends
Want to improve the targeting of your therapy?